Drug management in acute kidney disease - Report of the ADQI XVI meeting.
King's College London, Guy's & St Thomas' NHS Foundation Hospital, Department of Intensive Care, London, UK.
Veterans Affairs Medical Center, Department of Medicine, Washington, DC, USA.
Royal Surrey County Hospital NHS Foundation Trust, Intensive Care Unit, Guildford, UK.
University of Pittsburgh School of Pharmacy, Pittsburgh, USA.
Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, USA.
Department of Medicine, University of Chicago, Chicago, USA.
UCD School of Medicine, Health Sciences Centre, University College Dublin, Dublin, Ireland.
Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, International Renal Research Institute of Vicenza, Vicenza, Italy.
Cincinnati Children's Hospital Medical Center, Division of Nephrology and Hypertension, Cincinnati, USA.
- Published Article
British Journal of Clinical Pharmacology
Wiley (Blackwell Publishing)
- Publication Date
Oct 11, 2017
Drug management during different phases of AKD requires an individualised approach and frequent re-assessment. More research is needed to avoid drug associated harm and therapeutic failure.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29023830